Minoxidil: topical, oral and the evidence

Start with the formulation

Minoxidil applied to the scalp can help some forms of androgenetic thinning. Results take time and vary; benefit tends to diminish after stopping. Local reactions such as irritation and scaling can occur.

Oral minoxidil use for alopecia in the cited studies is off-label. It is a separate decision to discuss with a clinician. A skin solution must not be swallowed. Research on one formulation does not justify substituting another or deriving a personal dose.

What the comparisons show

In the 2024 JAMA Dermatology trial, oral minoxidil did not demonstrate superiority over topical treatment at 24 weeks in the men studied. Another trial published in September 2026 was not designed to establish equivalence or non-inferiority. These findings do not show that both routes are identical for everyone or free of long-term risks.

A precaution involving other people

EMA required a warning about excessive hair growth in children after accidental exposure to topical minoxidil, including contact with treated areas on caregivers. Avoid such contact; consult a doctor if this change appears.

Check the right document

Indications and precautions, including those concerning pregnancy and breastfeeding, depend on the product. The current Italian summary of product characteristics for a specific minoxidil medicine was not retrieved directly from AIFA’s database in this research. This guide therefore does not serve as its official product sheet.

Before deciding, ask a doctor or pharmacist to check the exact product and its current leaflet. Bring your list of other medicines too: “topical” does not automatically mean that no precautions apply. This English edition retains the Italian regulatory context; it does not establish licensing in another country.